The Virtual CVOT Summit 2025 will start on 20 November at 15:00 CET.The livestream will start today at 15:00 CET.Thursday, 20 November 2025Welcome and Introduction15:00 – 15:10 CETOliver Schnell (Munich, Germany)New Horizons in Cardiovascular, Kidney and Metabolic Care15:10 – 16:15 CETChairs: Jennifer Green (Durham, NC, USA), John McMurray (Glasgow, UK)On the Evolution of CardioVascular Outcome Trials (CVOTs)15:10 – 15:25Scott Solomon (Boston, MA, USA)SURPASSing Previous Boundaries: Incretine Mimetics and Cardiorenal Outcomes15:25 – 15:45Stefano del Prato (Pisa, Italy)The Aldosterone Pathway Revisited: Novel Approaches in Hypertension Management15:45 – 16:00Michel Azizi (Paris, France)Discussion16:00 – 16:15From Study to Guideline to Practice: Making Clinical Evidence Work16:15 – 17:30 CETChairs: Helena Rodbard (Rockville, MD, USA), Frank Tacke (Berlin, Germany)Perspectives of the Guideline Workshop (1) Obesity: New Opportunities for Network Meta-Analyses16:15 – 16:30Arnav Agarwal (Hamilton, Canada)Perspectives of the Guideline Workshop (2) Implementation of Guidelines at National Level: Perspectives of the European Renal Association (ERA)16:30 – 16:45Christoph Wanner (Wuerzburg, Germany)Breaking Barriers in Hard to Control Hypertension: Key Insights for Practitioners16:45 – 17:00Kamlesh Khunti (Leicester, UK)Putting Person-Centered Care into Practice: What Matters to Patients with Chronic Liver Disease17:00 – 17:15Marko Korenjak (Brussels, Belgium)Discussion17:15 – 17:30Break17:30 – 17:45Policy Session: Transforming Cardiometabolic Health: Advancing Science, Integrated Care and Policy17:45 – 18:30 CETChair: Oliver Schnell (Munich, Germany)EU Policies to Improve Cardiovascular Health17:45 – 17:55MEP Romana Jerković (Brussels, Belgium)Towards an Inclusive EU CV Plan17:55 – 18:05Chantal Mathieu (Leuven, Belgium)Cardiovascular Health: How to Transition to National Progress18:05 – 18:15Dirk Müller-Wieland (Aachen, Germany)Hellmut Mehnert Award18:30 – 19:30 CETChairs: Rury Holman (Oxford UK), Eberhard Standl (Munich, Germany)Introduction of the Award18:30 – 18:40Eberhard Standl (Munich, Germany)Laudation and Presentation of Awardee18:40 – 18:45Rury Holman (Oxford, UK)The Discovery of Multi-Receptor Drugs: The end of obesity and type 2 diabetes?18:45 – 19:25Matthias Tschöp (Munich, Germany)Closing19:25 – 19:30Rury Holman (Oxford UK), Eberhard Standl (Munich, Germany)Oral Presentations – Part 119:30 – 20:15 CETChairs: Dipesh Patel (London, UK), Nikolaos Papanas (Alexandroupolis, Greece)OP 1: Prediabetes Remission and Long-Term Risk of Cardiovascular Death, Heart Failure Hospitalization, and All-Cause Mortality19:30 – 20:15Andreas Birkenfeld (Tuebingen, Germany)OP 2: Clinical association of diabetes mellitus and heart failure with metabolic dysfunction-associated steatotic liver diseaseKateryna Pivtorak (Vinnytsia, Ukraine)OP 3: Relationship between undiagnosed diabetes, cardiovascular events and mortality in acute coronary syndrome patients enrolled in the STRONG-MI registryFaisal Aziz (Graz, Austria)OP 4: Influence of Diabetes Mellitus on Thrombosis in Branch Retinal Vein OcclusionMarianne Shahsuvaryan (Yerevan, Armenia)Closing of Day 120:15 CETOliver Schnell (Munich, Germany)The livestream will start today at 08:45 CET.Friday, 21 November 2025Advancing Early Detection and Preventive Strategies in Type 1 Diabetes08:45 – 09:30Chair: Thomas Danne (Lisbon, Portugal)C-Peptide as a Surrogate Parameter for Residual Beta Cell Function in Type 1 Diabetes and its Potential Clinical Role08:45 – 09:00Colin M. Dayan (Cardiff, UK)Targeting Autoimmunity in Type 1 Diabetes: Emerging Disease-Modifying Strategies09:00 – 09:15Chantal Mathieu (Leuven, Belgium)Discussion09:15 – 09:30Continuous Monitoring: Current and Emerging Perspectives09:30 – 10:45 CETChair: Julia Mader (Graz, Austria)The Heartbeat of Glucose: CGM’s Role in Cardiovascular Outcomes in Diabetes09:30 – 09:45 Tadej Battelino (Ljubljana, Slovenia)Building CGM Expertise: Recommendations for Education and Practice09:45 – 10:00Pratik Choudhary (Leicester, UK)Continuous Ketone Monitoring: A New Era in Metabolic Management10:10 – 10:15Susanne Reger-Tan (Bad Oeynhausen, Germany)Discussion10:15 – 10:30 Break10:30 – 10:40 CETSatellite Symposium See Further, Act Smarter: How AI Is Transforming Diabetes Care10:40 – 10:55 CETJohn Pemberton (Birmingham, UK) Supported by Roche Diagnostics International Ltd.Break10:55 – 11:00 CETThe Silent Link: Diabetes and Chronic Kidney Disease11:00 – 12:00 CETChairs: Rury Holman (Oxford, UK), Paola Fioretto (Padua, Italy)Kidney Protection in Type 1 Diabetes: Are Non-Steroidal MRAs the Next Step? 11:00 – 11:15Hiddo Heerspink (Groningen, The Netherlands)SGLT2 Inhibitors and Non-Steroidal MRAs: Combining Forces for Cardiorenal Protection11:15 – 11:30Johannes Mann (Munich, Germany)Future Directions in the Treatment of Chronic Kidney Disease11:30 – 11:45Parminder Judge (Oxford, UK)Discussion11:45 – 12:00Integrated Approaches in Heart Failure Therapy12:00 – 13:00 CETChair: Naoki Sato (Kawaguchi, Japan), Henrike Arfsten (Vienna, Austria)SGLT2 Inhibitors – Changing the Game in Heart Failure Treatment12:00 – 12:15Nikolaus Marx (Aachen, Germany)Changing Landscape in HFpEF: New Therapeutic Strategies12:15 – 12:30 Pardeep Jhund (Glasgow, UK)Emerging Treatment Strategies in HFrEF12:30 – 12:45Giuseppe Rosano (London, UK)Discussion12:45 – 13:00Break13:00 – 13:30Multidisciplinary Strategies in Obesity and Metabolic Liver Disorders13:30 – 15:00 CETChairs: Matthias Blüher (Leipzig, Germany), Linong Ji (Beijing, China)Obesity 2025 – State of the Art in Diagnosis and Therapy13:30 – 13:45Timothy Garvey (Birmingham, AL, USA)One Target Is Not Enough? Novel GLP-1-Based Treatment Approaches13:45 – 14:00Sean Wharton (Toronto, Canada)Discussion14:00 – 14:15The Liver in Distress: Managing Obesity-Related MASLD14:15 – 14:30Elisabetta Bugianesi (Turin, Italy)Nutrition Under Incretin Therapy14:30 – 14:45Andreas Pfeiffer (Berlin, Germany)Discussion14:45 – 15:00The Global Alliance for Cardio-Kidney-Metabolic Care – Holistic Approaches to Improve Clinical Care15:00 – 15:30 CETChairs: Stephan Jacob (Villingen-Schwenningen, Germany), Andrew Krentz (London, UK)Beyond LDL Lowering: Managing the Residual Risk in ASCVD15:00 – 15:15Peter Libby (Boston, MA, USA)Why Do We Need to Establish Cardio-Metabolic-Renal Care and Beyond?15:15 – 15:30Robert Eckel (Denver, CO, USA)Practical Implementation in Primary Care: A Hands-On Session15:30 – 16:30 CETChairs: Pinar Topsever (Istanbul, Turkey), Baruch Itzhak (Haifa, Israel)Why Early Diagnosis Matters, and How to Put It into Practice in Chronic Kidney Disease15:30 – 15:45Ana Cebrian (Murcia, Spain)Supporting Patient Adherence – Practical Strategies for Clinical Practice15:45 – 16:00Katharine Barnard-Kelly (Hampshire, UK)Translating Guidelines into Practice: A Heart Failure Nurse’s Perspective16:00 – 16:15Ekaterini Lambrinou (Limassol, Cyprus)Discussion16:15 – 16:30Break16:30 – 16:45Industry’s perspective - Panel Discussion16:45 – 17:45 CETOliver Schnell (Munich, Germany)Oral Presentations – Part 217:45 – 18:30 CETChairs: Banshi Saboo (Ahmedabad, India), Antonio Ceriello (Milan, Italy)OP 5: A Time In Range of 70% Attenuates the Senescence-Inducing and Pro-Inflammatory Effects of Hyperglycemia17:45 – 18:30Rosalba La Grotta (Milan, Italy)OP 6: Monitoring ketone levels continuously during a 7-day fastNina Jendrike (Ulm, Germany)OP 7: Routine Biopsychosocial Care Is Practical and AchievableKatharine Barnard-Kelly (Fareham, UK)OP 8: Pharmacist-Led Consultations for Continuous Glucose Monitoring Users: Knowledge, Confidence, and Opportunities to Support Diabetes Management and OutcomesAnastasija Levkina (Vilnius, Lithuania)Abstract Award and Closing18:30 – 18:45 CETOliver Schnell (Munich, Germany) Thank you for your attendance and contribution to the Virtual CVOT Summit 2025. See you next year for the 12th CVOT Summit on 19 - 20 November 2026. We will be right back.We are currently having some technical issues. We will be right back.The page is automatically updated.The next program item is loaded.
